Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-025130

Director bought 1,600 shares at $20.04 ($32,064)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Leversage Jill Director 2021-12-13 Purchase +1,600 $20.04 $32,064 5,300 D: show line 1 in the form
Open-market purchases · 1,600 sh · avg $20.04 · $32,064
Loading xslF345X03/wf-form4_163960257768858.xml…